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ABSTRACT 
Background: Reports on the global incidence of oral neoplasms indicate reduced 
data from Africa. Population based studies of oral cancer in Sudan and other regions 
of Africa are scarce. Oral cancer in Sudan constitutes a serious health problem, and 
squamous cell carcinoma (SCC) is the most prevalent type of oral malignancy. There 
are descriptive epidemiologic studies from Sudan that have reported high a frequency 
rate of oral cancer in Sudanese males, linking this high incidence to Toombak, a 
product of oral snuff mixed with sodium bicarbonate (Idris et al, 1995(b)), but to date 
no population-based studies of oral cancer incidence in Sudan have been performed or 
published. 
Title: Epidemiology of Oral Malignancy in Sudan (2004-2008). 
Aims and Objectives: The objectives of the study were to analyse the pattern of 
distribution and to determine the minimum age standardized incidence rates (ASIR) 
and the cumulative (lifetime) risk (CR) of oral & lip squamous cell carcinoma / oral 
malignancy by site, age and gender for the 5-year period 2004 -2008. 
Methods: The records of patients with oral & maxillofacial and salivary 
malignancies (OMFS) referred to Khartoum Dental Teaching Hospital (KDTH) and 
the population census data were accessioned. Data was captured using Microsoft 
Excel 2007® and the ASIRs for oral squamous cell carcinoma (OSCC) were 
calculated using the direct International Agency for Research on Cancer (IARC) 
method. These results were compared with the on-line global cancer statistics 
database (GLOBOCAN - WHO/IARC) for 2008 and 2012. Records of oral cancer 
cases during the period of the study were obtained from KDTH. The information 
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included in the raw data collected were the file number for patient identification, year 
of diagnosis, age, sex, site of the lesion, histological diagnosis, the International 
Classification of Diseases-10 (ICD10) codes, the referring unit and the state from 
which the patient was referred. The population data for the years of the study and the 
five age group stratifications was obtained from the Central Statistical Office in 
Khartoum, Sudan. The data was analysed using Microsoft Excel, 2007®. Age 
standardized incidence rate of oral & lip squamous cell carcinoma/ oral malignancy 
was calculated using the direct IARC method. 
Results: Of the total Sudanese population of 36.3 million in 2006, 649 OMFS 
malignancies (M : F=1.44:1) were captured at KDTH during the 5-year period; 390 
(M : F=1.67:1) were (intra) oral squamous cancers (OSCC) and verrucous carcinomas 
(VC). The ASIR for OSCC/VC in Sudan was calculated as 3.19 for males and 1.83 
for females (M : F=1.74:1), however the pooled ASIR in the Khartoum and Gezira 
States was 30% higher for males (4.21) and 14% higher for females (2.09, M: 
F=2.01:1).  The incidence over the 5 years of separately recorded lip SCC/VC in 
Sudanese males was 26 and 8 for females (M : F=3.25:1). The ASIRs of combined 
oral & lip SCC/VC in Sudanese males was 3.45 and 1.88 for females (M : F=1.84:1). 
These compare relatively well with the GLOBOCAN data which estimates a slightly 
lower ASIR of 3.3 for males and somewhat higher ASIR of 2.1 for females (M : 
F=1.57:1). The cumulative (lifetime) risk (CR 0-74) of developing oral and lip cancer 
was 1: 182 for males compared to 1: 831 for females. For oral cancer (excluding lip), 
the CR was almost similar for males (1: 181); while females showed a markedly 
higher CR (1: 344). 
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Conclusion: The combined ASIRs of oral & lip SCC/VC from the Khartoum and 
Gezira states differed from the ASIRs calculated for the entire Sudan and from the 
GLOBOCAN estimates. The recording of cancer incidence data can vary according to 
the (incorrect) labelling of anatomical locations and diagnosis. The numbers are 
influenced by geo-political, environmental and socio-economic factors, and referral 
bias. 
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CHAPTER 1 
1. INTRODUCTION 
Oral cancer is an increasing health problem world-wide. However, its distribution 
varies widely in different populations. The epidemiology of cancer is influenced by 
the geographical environments, variation in age, sex, and site, climates and associated 
risk factors. 
Globally oral cancers combined with pharyngeal cancer are the sixth most prevalent 
cancers in males the world and follows lung cancer, stomach, breast, colon/ rectum 
and cervix/ corpus uteri cancer. The estimated annual incidence for oral cancer was 
around 275,000 with the majority of these cancers occurring in the developing 
countries (Warnakulasuriya, 2009).  
Unfortunately, comprehensive population-based studies of oral cancer in Sudan and 
other African regions show limited numbers.  The available statistics from descriptive 
studies showed that the incidence of oral cancer in Sudan is higher among males 
compared to females (Idris et al, 1998; Idris et al, 1995(a, b); Idris et al, 1992). The 
lack of reliable data has emphasised the need for Sudan to develop means of data 
gathering in order to address the cancer scourge. An updated analysis of oral cancer 
distribution in the Sudan is nevertheless needed.  
The most common risk factor associated with oral cancer in Sudan is Toombak, a 
form of smokeless tobacco with high carcinogenic potential due to high contents of 
tobacco-specific nitrosamines. Toombak has been extensively investigated in previous 
studies and conflicting results regarding the carcinogenic potential of this product and 
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its potential relationship with oral cancer have been reported (Idris et al, 1991; 1992; 
1995(a); 1996, 1998). 
The purpose of this study was to analyse the pattern of distribution and the incidence 
rates of oral cancer for patients who attended the Khartoum Dental Teaching Hospital 
(KDTH) during the five years of the study. It was felt that a descriptive analysis of 
oral cancer data archived at this main referral hospital for oral cancer in the country 
could aid in assessing the extent of the problem. Furthermore, this study could also 
facilitate categorising the population in risk groups, thereby helping to assign 
resources for higher risk population groups. The research is also aimed at establishing 
a series of future studies on the oral cancer incidence in Sudan to enable comparison 
with global data and possibly tracking future changes in the local trends of oral and 
oropharyngeal cancer.  
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Figure 1: The Republic of Sudan 
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CHAPTER 2 
2. LITERATURE REVIEW 
2.1 Introduction: 
The literature revealed a great lack of consistency in defining the term oral cancer. 
The anatomy of the oral cavity is very complex. The oral cavity proper consists of 
different sites e.g. tongue, palate, gum, floor of mouth, retro-molar area and the lip. 
Malignancies arising in the oral cavity are complicated by the presence of different 
origin tissue types such as oral mucosa, salivary glands, jaw bones, lymphoid tissue 
and supporting structures. This is further influenced by the presence of the skin 
covering the lips and the area of the vermilion border which is believed by many 
researchers to include a cohort of skin-associated tumours in fair-skinned individuals. 
This variability in the term oral cancer complicates the interpretation of the 
epidemiological data of oral cancer (Tapia and Goldberg, 2011).   
Oral and pharyngeal cancers grouped together are ranked as the sixth most common 
cancers in the world. Ninety percent of upper aero-digestive tract malignancies are 
squamous cell carcinomas (SCC). Data of oral cancer from Africa is scarce and global 
incidence studies of oral neoplasms showed reduced data from Africa 
(Warnakulasuriya, 2009). 
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2.2  Epidemiology: 
2.2.1 Global epidemiology 
Oral cancer is a global health problem which has a profound effect on the general 
health and the quality of life. Several studies have reported varying results on the 
global incidence and trend of oral and oropharyngeal cancer. However, in the past 
decade head and neck cancer was considered to be a heterogeneous disease. This was 
ascribed to the emergence of the subtypes of Human PapillomaVirus (HPV) - 
associated head and neck squamous cell carcinoma (HNSCC) and molecular 
demonstration of the heterogeneity of head and neck squamous cell carcinoma using 
advanced molecular techniques. This change in the biology and risk factor association 
in HNSCC is reflected in the change in the clinical and the biological characteristics 
of head and neck cancer (Leemans et al, 2011).   
According to the global statistics, the incidence of head and neck cancer showed great 
variation in the different geographical areas. In South and South East Asia, high 
incidence rates of oral cancer excluding lip cancer have been reported, followed by 
parts of Western and Eastern Europe, the Caribbean and parts of Latin America and 
the Pacific region. Carcinoma of the oral cavity is the most common cancer in men in 
countries with increased risk factors such as India, Bangladesh, Sri Lanka, and 
Pakistan, accounting for 25% of new cancer cases per year (Warnakulasuriya, 2009). 
In the past twenty years, the age standardized incidence of oral cancer showed a 
steady increase in some parts of Europe. This rise in the trend of oral cancer in those 
countries has been attributed to increased use of tobacco and alcohol consumption 
(Warnakulasuriya, 2009). According to the European Union 2004 report, 
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oropharyngeal cancer is the 7th most prevalent cancer. France and Hungary reported 
the highest incidence within the European Union. The lifetime risk of developing 
oropharyngeal cancer in the European Union was estimated as 0.37% for females and 
1.85% for males (Black et al, 1997; Warnakulasuriya, 2009). In the United Kingdom 
(UK), oral and pharyngeal cancers accounted for 1.6% of all cancer cases reported in 
2003, making UK one of the European countries with the least reported cases of oral 
and pharyngeal cancer.  However, recent studies have shown that the disease is on the 
increase in young adults in the UK. Most of UK cancer registries record 6% of the 
total oral cancer cases in young adults less than 45 years of age (Conway et al 2006). 
Robinson and Macfarlane (2003) reported an increase in oropharyngeal cancer in 
males (31%) and (16%) for females during 1989-1996 in Scotland. The changes 
involved principally males aged 34-65 years despite the stable mortality rate 
(Robinson and Macfarlane, 2003). 
The United States of America (USA) reported a declining trend of oral and 
pharyngeal cancer by 1.5% for all races (Warnakulasuriya, 2009).   
In Hungary the incidence and mortality of oropharyngeal cancer have doubled in 
recent decades. Other countries in central Europe, e.g. Slovenia and Slovakia, have 
also reported increasing rates of oral cancer (Banoczy and Squier, 2004). 
In a retrospective population based study in Nova Scotia for the period of 1983-1997, 
oral cancer accounted for 2% of all cancers. Lip cancer was the most prevalent site 
followed by the tongue. Fifty-three percent of oropharyngeal and lip cancers occurred 
above the age of 65 years. There was a dramatic increase in intraoral cancer in 
females and a lower increase in males (Howell et al, 2003). 
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The most frequently reported types of cancers in male Indians were cancers of the oral 
and pharyngeal sites, followed by oesophageal, lung, and laryngeal and stomach 
cancers. In the same manner, Singapore male Indians reportedly endure an increased 
rate of oropharyngeal cancers followed by lung and stomach cancers, but prostatic 
and colorectal cancers replaced oesophageal and laryngeal cancers in the most 
common five malignancies reported (Rastogi et al, 2008). More than 100,000 cases of 
oral cancer are registered per year in India. Some districts in India have the highest 
world incidence of tongue and mouth cancer; 6.1 per 100 000 and 7.1 per 100 000 
respectively (Curado et al, 2007).  
In Jordan a descriptive epidemiological study on malignant oral tumours (1991-2001) 
concluded that in north Jordanians, squamous cell carcinoma was the most common 
oral malignant tumour accounting for more than 84% of all oral malignancies. Other 
histological types included were: sarcomas 5.6%, adenocarcinomas 5.6%, and 
lymphomas 4%. Mouth NOS was the most common site affected (42.4%) followed by 
the lip (33%) and tongue (24%). In comparison with other international studies there 
was a low incidence of mouth and tongue cancer. Lip malignancies were the second 
most common tumours of the oral cavity in north Jordan while in global terms they 
showed lower incidence rates. Risk factors such as smoking, exposure to solar 
radiation and possible dietary factors have been recognized in the aetiology of oral 
cancer in Jordan (Rawashdeh and Matalka, 2004). 
2.2.2 Epidemiology of head and neck cancer in Africa 
There are only a few population based studies of oropharyngeal cancer from the 
African continent (Warnakulasuriya, 2009; Johnson, 1991). Curado et al (2007) 
described in “Cancer Incidence in Five Contents, Volume IX”, which indicate that the 
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only male populations in Africa that reported a mouth cancer rate of 1.0 per 100 000 
per annum and above were those of Uganda, Kyadondo County (1.6 per 100 000), 
Egypt, Gharbiah (1.3 per 100 000), and Tunisia, Centre, Sousse (1.0 per 100 000). 
Only females in Egypt, Gharbiah and Uganda, Kyadondo County showed a rate of 1.0 
per 100 000.  
Hille et al (1996) reported oral cancer incidence rates of (all sites combined) in South 
Africa in 1988-1991. They did find a male preponderance in black, coloured and 
white groups, while females are affected more frequently in the Asian population.  
Lip cancer showed the highest age standardized incidence rate (ASIR) in white males. 
However, the trend of lip cancer showed a decline in the incidence rate compared to 
previous studies in their country. Altini and Kola (1985) reviewed oral SCC (OSCC) 
incidence rates in black subjects on the Witwatersrand, South Africa, for the period 
1971-1980. They reported a tongue cancer incidence rate of 1.3 per 100 000 per year 
in black females. 
Marimo and Hille (2006) concluded from a population-based study in Zimbabwe that 
oral malignancies comprise 1.8% of the total body malignancies. Lip cancer was three 
times more common in whites than blacks, and the most affected age group was the 
elderly. SCC and Kaposi sarcomas were the leading malignancies. There was an 
increased rate of Kaposi sarcoma among adults which was attributed to the HIV/AIDS 
epidemic in the region.  
Another descriptive epidemiological study in a Zimbabwean population showed that 
squamous cell carcinoma was the most common malignancy, involving 
predominantly mandibular gingiva. SCC of the floor of the mouth and tongue were 
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found to be the second and the third sites involved. Lip cancer was uncommonly 
reported (Chidzonga and Mahomva, 2006). 
Another study done on the East African population in Muhimbili Hospital in Tanzania 
and Mulago referral hospitals in Uganda concluded the following: In Tanzania, SCC 
was the most common type of malignancy (32.75%), followed by Burkitt’s lymphoma 
(32.40%) and Kaposi sarcoma (15.14%). Only one case of malignant odontogenic 
neoplasm (malignant ameloblastoma) was reported. On the contrary, in Uganda, 
Kaposi sarcoma was the most common malignancy accounting for (37.78%), 
followed by Burkitt’s lymphoma (30.12%) and then SCC (19.67%). Regarding the 
gender distribution, most of the cases occurred in males. The age distribution showed 
a great variability for the different neoplasms. The second and third decades were the 
most common age distribution for most of the neoplasms; the sixth decade was the 
most frequent age for squamous cell carcinoma. The peak age for Burkitt’s lymphoma 
was below 10 years, while 56.4% of the dominant malignancies in the sixth decade 
upwards were Kaposi sarcoma. Most of the mandibular lesions were ameloblastomas 
and no gender specific incidence was reported (Kamulegeya and Kalyanyama, 2008). 
2.2.3 Oral cancer in Sudan  
Previous reports on oral cancer in Sudan revealed a relatively high frequency 
compared to the neighbouring countries (Idris et al, 1995(b)). The most common type 
of malignancy reported was SCC which accounted for (66.5%), followed by tumours 
of the salivary glands (14.7%), neoplasms of non-odontogenic & non-epithelial origin 
(9.6%) and odontogenic neoplasms (8.6%). The frequency showed a high level of oral 
cancer in men compared to women. The older age groups of both genders showed a 
relatively high frequency of squamous cell carcinoma. Northern Sudanese suffer from 
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a high rate of SCC while southern Sudanese endure a higher rate of odontogenic and 
salivary gland neoplasms (Idris et al, 1995(b)). However, no site specific distribution 
pattern for intraoral malignancy has been reported. 
Osman et al (2010) analysed the stage of presentation of 261 cases of malignant 
tumours registered at Khartoum Dental Teaching Hospital. They observed that most 
of the patients attending the hospital at a very late stage (94% of patients) were stage 
IV tumours. They also revealed that 66.3% of the  attendees had clinically involved 
regional lymph node involvement. The economic status of the  patients indicated  that 
about 36% were from low socio-economic groups and 51.6% were dependent on 
other members of the family. 
Idris et al (1992) demonstrated the aetiological association between the use of 
Toombak and SCC. This was linked to the high level of tobacco-specific nitrosamines 
in Sudanese snuff (Toombak), which was present at high concentrations in the saliva 
of oral snuff Sudanese users (Idris et al, 1991; 1992). The authors suggested that the 
distribution pattern of oral cancer in Sudan was influenced by factors such as the 
distance, transportation difficulties, socio economic factors, lack of education, and 
other factors preventing patients from seeking medical care (El-bashir et al, 1989; 
Idris et al, 1992). 
According to Templeton et al (1972) and Davis et al (1985), the pattern of neoplasms 
reported in Africa was endogenous to some African regions and similar types of 
neoplasms were seen in the neighbouring countries. They attributed this pattern to 
local environment, dietary factors, microbial agents and/or climate that influences the 
aetiology of these tumours. 
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2.2.4 Age, gender and site prevalence 
Oral cancer is a disease that is greatly affected by the age stratification of the 
population, with 98% of patients being over 40 years of age. It is considerably more 
common among male gender in most countries. In Britain, lip carcinoma was eight 
times more common in men compared to women. Intraoral cancer used to be several 
times more frequent in males than females but the overall male to female ratio was  
3:2, and in South East England recent figures showed little difference between the 
genders. This change was thought to be due to the progressive decline in the incidence 
in men with a static rate in women (Cawson and Odell, 2008). On the other hand 
tongue cancer was the most prevalent cancer in the United States, with an estimated 
percentage of 40-50% of oral cancers. In Asians, the buccal mucosa was the most 
common site for intraoral cancer (Warnakulasuriya, 2009). This distribution pattern 
was suggested to be linked to the habit of betel quid chewing (Warnakulasuriya, 2009; 
Byakodi et al, 2012). In a recent study, the lower alveolus was the most common site 
of involvement with oral cancer in India (Byakodi, 2012). 
An epidemiologic and clinical oral cancer study conducted in India reported that 
carcinoma of the palate was associated with smoking and alcohol consumption. On 
the other hand lower alveolar mucosa and buccal mucosa were associated with 
chewing tobacco (Byakodi et al, 2012). In the past decade, the change in the trend of 
head and neck cancer was thought to be due to the impact of lifestyle factors and 
Human Papilloma virus (HPV) paralleled with a shift in the age, with younger age 
groups being affected (Westra, 2009). 
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2.3 Risk factors: 
2.3.1 Established and possible risk factors 
The incidence of oral cancer is influenced by many factors such as nutritional, 
immunological, occupational and other habitual, genetic, infectious and 
socioeconomic risk factors (Curado et al, 2009). The epidemiology of head and neck 
cancer showed recent changes in the trend and the risk factors association. Tobacco-
associated head and neck cancer appears to be decreasing in men and beginning to 
rise in women. Tobacco and alcohol have been considered to play a very important 
role in the aetiology of oral cancer (Curado et al, 2009). The association of tobacco 
smoking and oral cancer is dose dependant (Petti, 2009). Human PapillomaVirus 
(HPV) infection, as discussed later, was suggested to be a factor of good prognosis in 
squamous cell carcinoma of the oral cavity and oropharynx (Curado et al, 2009). 
Petti (2009) discussed the risk factors associated with head and neck cancer in detail. 
According to Warnakulasuriya (2009) alcohol and all forms of tobacco, including 
smokeless forms and snuff dipping, are considered well established risk factors for 
oral cancer. The author also mentioned that sunlight and radiation are potential risk 
factors for lip cancer.  
The most common forms of smoking found in western and developing countries were 
cigarettes, cigars, cheroots, tobacco in pipes or handmade cigarettes. The different 
types vary in their tar and nitrosamine content, the method of combustion, the additive 
materials and methods of curing. There is significant association between smoking 
habit and the prevalence of OSCC. Marijuana usage has been recently identified as an 
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independent risk factor in HPV associated HNSCC (Westra, 2009, Gillison et al, 
2008). 
Possible risk factors for oral cancer also include HPV, immunodeficiency and 
ethnicity. Furthermore, mouth washes, genetic factors and periodontal disease are 
speculative risk factors for oral cancer development (Warnakulasuriya, 2009). 
The low levels of mouth cancer in females compared to males and the increased risk 
of oral cancer in post-menopausal women may suggest the involvement of hormonal 
factors in the aetiology of oral cancer. High blood glucose and estrogen deficiency 
were suggested to be risk factors in females (Suba et al, 2009). 
Some studies linked chronic trauma of the oral mucosa to oral cancer, especially when 
other risk factors are present (Piemonte, 2010; Lockhart et al, 1998). 
2.3.2 Toombak 
This is the most popular form of smokeless tobacco found in Sudan. It is made locally 
from tobacco powder that contains a high level of nicotine called Nicotiana Rustica 
and sodium bicarbonate, with a 4:1 ratio. The alkalinity of sodium bicarbonate 
increases the absorption of the nicotine from the mucosal surfaces (Idris et al, 1998). 
The habit of snuff dipping in Sudan is confined almost exclusively to males, with a 
daily consumption rate of 10 to 20 dips (Idris et al, 1998). The elevated risk found 
when investigating intraoral cancer sites in direct contact with Toombak compared to 
those with little or no contact, confirms the hypothesis that direct contact with the 
tissues is an important factor in the carcinogenesis of Toombak (Idris et al, 1995(a)). 
The most substantial evidence of the association between SCC and the use of 
Toombak is evident in the study of 62 patients of squamous cell carcinoma, 81% of 
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whom had used Toombak and the site of carcinoma was the site where the quid was 
kept (El-bashir, et al, 1989). The oral application of snuff in rats induces malignant 
tumours of the palate, gingival and tongue (Johansson et al, 1989). Studies have 
established and quantified several carcinogens in snuff including N-nitrosamines, 
volatile aldehydes, polycyclic aromatic hydrocarbons (PAH) and polonium-210 (Petti, 
2009; Hoffmann et al, 1987; Djordievic et al, 1993). The N-nitrosamines (volatile and 
non-volatile) have been reported to be the most abundant carcinogens. The tobacco-
specific nitrosamines (TSNA) derived from nicotiana alkaloids contribute about 70-
90% of the total N-nitrosamines. Among these TSN the N-nitrosonornicotine (NNN) 
and 4-(methyl nitrosamine)-1-(3-nitrosonicotine pyridyl)-1-butanone (NNK) are very 
strong carcinogenic factors in many species (Petti, 2009; Hecht and Hoffmann, 1989). 
The carcinogenic potential of tobacco chewing is well established and is dependent on 
the dose, while the carcinogenic potential of snuffing is less prominent with some 
evidence from human studies (Petti, 2009; IARC, 2006; Warnakulasuryia and Ralhan, 
2007; Weitkunat, 2007). The presence of NNK metabolites in Toombak suggests that 
the TSNA could be responsible for neoplastic transformation in the oral mucosa of 
Sudanese Toombak users (Idris et al, 1991, 1992). An association between the longer 
duration of Toombak use and oral cancer has been suggested. However, inconsistent 
results were observed from previous results regarding the effect of Toombak on the 
oral mucosa (Idris et al 1996; Ahmed and Mahgoob, 2007). 
A recent in-vitro study comparing the adverse effects of Sudanese Toombak and 
Swedish snuff on human oral cells concluded that Toombak has a higher potential to 
damage normal oral keratinocytes and normal oral fibroblasts than Swedish snuff. 
This effect was thought to be due to blockage of the G2/ M cell cycle and induction of 
apoptotic pathways. The study also found that higher cumulative adverse effects were 
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observed on the normal oral keratinocytes with the use of Toombak extracts when 
compared to Swedish snuff. On the contrary, less pronounced adverse effects were 
observed on dysplastic oral keratinocytes. Furthermore, it was suggested that the 
dysplastic oral keratinocytes were more prone to progress to malignant transformation 
by Toombak but not by Swedish snuff (Costea et al, 2010).   
Osman et al (2010) reported in a two year study conducted in Khartoum Dental 
Teaching Hospital that 28.7% of the oral cancer subjects were Toombak users and 
88% of those patients had SCC. Interestingly they also noted that 56% of the 
Toombak dippers showed overlapping lesions of the mouth compared to 31.7% in 
non-Toombak users.  
2.3.3 HPV and Head and Neck Cancer 
The Human Papilloma Virus (HPV) is a circular double stranded DNA virus. The role 
of the HPV in carcinogenesis has been extensively investigated, especially in cervical 
cancer (Rautava and Syrjänen, 2012; Zur Hausen, 2002). Data regarding the 
association of the HPV and oral cancer remains controversial (Pannone et al, 2011; 
Chaudhary et al, 2009). However epidemiological and molecular bases provide 
support that the virus plays an important role in oropharyngeal cancer. The viral 
subtypes associated with carcinogenesis are labelled high risk viruses. HPV16 in 
particular is linked to HNSCC (Pannone et al, 2011; Leemans et al, 2011). 
HPV associated SCC usually affects younger individuals (<40 years) with a male 
predominance. The histomorphology of this neoplasm shows non-keratinizing 
basaloid features. HPV associated SCC responds to chemo-radiotherapy and targeted 
immuno-stimulatory therapy (Pannone et al, 2011; Westra, 2009). A significant high 
relative risk of head and neck squamous cell carcinoma, associated with high risk 
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HPV, was evident among alcohol users. This suggests a synergistic effect between 
alcohol and HPV in the causation of the neoplasm (Pannone et al, 2011). On the 
contrary no synergistic effect between tobacco and HPV status was found (Pannone et 
al, 2011; Smith et al, 2004). 
Most researchers consider HPV-associated SCC as a distinct group of head and neck 
squamous cell carcinoma. This entity is considered to be associated with different 
aetio-pathological factors, histomorphology, different molecular characteristics as 
well as clinical characteristics and outcome, compared to conventional HPV negative 
HNSCC. HPV-associated HNSCC have a more favourable prognosis (Leemans et al, 
2011; Pannone et al, 2011; Rautava and Syrjänen, 2012). 
2.3.4 Molecular carcinogenesis of oral cancer: 
Agrawal et al (2011) and Stransky et al (2011) have demonstrated recent advances in 
the molecular pathogenesis of head and neck cancer using whole-exome sequencing 
performed on 100 HNSCC by the two studies. The fundamental roles of different 
molecular pathways involving HNSCC have been supported by many studies. These 
include molecular pathways involved in cellular proliferation and tumour suppressor 
function e.g. P53/ Rb/ INK4/ ARF / CCND1. Other pathways involved in terminal 
differentiation of cells, for instance P63/ Notch axis, have also been reported in a 
subset of HNSCC cases including HPV+ squamous cell carcinomas (Talora et al, 
2005). Pathways involved in cell survival, particularly EGFR and its downstream 
pathways such as Phosphatidylinositol-3 kinase (PIK3CA) and RAS are commonly 
activated in HNSCC. Epidermal Growth Factor Receptor (EGFR) pathways are 
considered to be the most important chemotherapeutic targets in HNSCC (Rothenberg 
and Ellisen, 2012; Sharafinski, et al, 2010). In addition, transforming growth factor β 
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pathways (TGF- β) and SMAD genes have also been linked to tumour initiation and 
metastasis (Rothenberg and Ellisen, 2012). A potential pathway is FAT1 gene 
mutations (Stransky et al 2011). Other potential gene targets with unclear functional 
significance in the causation of HNSCC are MLL2, NSD1 (Stransky et al 2011) and 
SYNE1 (Agrawal et al, 2011 and Stransky et al 2011). 
On the other hand, in HPV-associated SCC, the HPV early oncoproteins; E6 and E7 
interact with a variety of cell cycle genes and proteins (Rautava and Syrjänen, 2012). 
In particular the cell cycle regulator (p53) is affected by the former and 
retinoblastoma (RB) is affected by the latter (Leemans et al, 2011; Rautava and 
Syrjänen, 2012). The role of E5 viral oncoprotein was also investigated by Maufort 
and co-workers in 2010 (Maufort et al, 2010). E5 was found to cause continuous 
proliferation and delays differentiation of the keratinocytes. These effects are 
mediated through the interaction of the E5 oncoprotein with the epidermal growth 
factor receptor (EGFR) signalling pathway and platelet derived growth factor receptor 
(PDGF). Furthermore E5 oncoprotein enhances cell proliferation through down-
regulation of tumour suppressors; p21 and p27 (Rautava and Syrjänen, 2012).  
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CHAPTER 3 
3. AIMS AND OBJECTIVES 
3.1  Aim 
The aim of the study was to determine the incidence and to analyze the pattern of distribution 
of oral malignancies in Sudan for cases referred to Khartoum Dental Teaching Hospital 
during the 5 –year period, 2004-2008. 
3.2 Objectives 
The objectives of the study were: 
1- To determine the prevalence of oral, maxillary sinus and salivary gland malignancies by 
gender, site and age. 
2- To determine the minimum age standardized incidence rates (ASIR) and age specific rates 
of oral cancer by site and gender. 
3- To determine the cumulative (lifetime) risk (CR) to develop oral cancer for the population 
under the study. 
4- To compare the incidence rates of oral cancer to the corresponding GLOBOCAN figures. 
3.3 Hypothesis 
The incidence of oral and lip squamous cell carcinoma in the Sudanese population reflects 
male predominance.   
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CHAPTER 4 
4. STUDY DESIGN AND METHODOLOGY 
4.1 Study design 
This was a retrospective, descriptive and analytic epidemiological study based on the 
study of data recorded at Khartoum Dental Teaching Hospital (KDTH) for the 5-year 
period (January 2004 - December 2008). 
4.2 Study population and sampling 
The data included in this study was obtained from Khartoum Dental Teaching 
Hospital for all patients with oral cancer recorded in the period of the study between 
January 2004 and December 2008. These records were based exclusively on 
histological biopsy reports referred from the national and private laboratories and the 
Pathology Department of the University of Khartoum. To prevent duplication other 
hospitals were not included in the study since almost all of the oral cancer cases were 
referred to Khartoum Dental Teaching Hospital for management. 
4.3 Inclusion criteria 
Data of all Sudanese residents newly diagnosed with malignant tumours during the 
period of the study (2004-2008) were included. The cases were classified into 
squamous cell carcinoma (SCC)/verrucous carcinoma (VC) and non-squamous 
groups. Intraoral cancer sites are classified according to the ICD-10 codes (Appendix 
2).  
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4.4 Exclusion criteria 
Patients with laryngeal and pharyngeal cancers were not included in the study as those 
patients were referred to the ear nose and throat units (ENT) for management. 
Metastatic lesions to the oral cavity were excluded from calculations of ASIRs. 
4.5 Data capturing 
All the records of oral and maxillofacial cases referred to KDTH during the period of 
January 2004 to December 2008 were obtained in a Microsoft Excel spreadsheet. The 
information included in the raw data was the file number for patient identification, 
year of diagnosis, age, sex, site of the lesion, histological diagnosis, the international 
classification of diseases-10 (ICD10) code ( appendix 2), the referring unit and the 
state from which the patient was referred. 
The raw data included the following sites: lip, tongue, gum, palate, floor of mouth, 
mouth NOS, maxillary sinus, jaw bone and major salivary glands.   
4.6 Data analysis 
The anatomical sites used to calculate (ASIRs) were lip, tongue, gum, palate, floor of 
mouth and mouth NOS. The latter five sites were designated as oral. Cancer cases 
from these sites were classified based on the histological diagnosis into SCC/VC and 
non-SCC. These groups were further separated into males and females.  Each gender 
category was divided into five year age groups from 0-4 to 75+. Only the groups 
marked SCC/VC in each site were used to measure the ASIR for SCC/VC. 
Calculation of all oral malignancy ASIRs included both SCC and non-SCC for oral 
sites collectively. 
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The population data and the estimated population size for each age group for males 
and females were obtained from the central statistical office, Khartoum, Sudan. The 
population statistics obtained also included state specific population data. The 2006 
statistics were used to calculate the age specific morbidity rate, adjusted age specific 
incidence rate; also known as ASIR, cumulative (lifetime) risk (CR) for oral cancer. 
The direct method described by the International Agency for Cancer Research (IARC) 
(Curado et al, 2007) was used to calculate the incidence and the cumulative risk 
estimates:   ASIRs per 100 000 and CRs (0-74) for oral SCC/VC,  combined oral and 
lip SCC/VC, lip SCC/VC and the total oral malignancies for all Sudanese patients 
referred to KDTH. Male and female ASIRs were designed separately. Adjustment for 
unknown age was made according to IARC method. 
Similarly, ASIRs for oral SCC/VC and combined oral & lip SCC/VC were calculated 
for Khartoum and Gezira states separately.  
All the calculations were conducted using Microsoft Excel 2007®, no data packages 
or other statistical tests were needed for the analysis. 
4.7 Definition of terms and formula used in calculation of age 
standardized rates: 
Crude incidence rate: - 
Is the rate at which new cases occur in a population during a specific period of time. 
This rate is expressed as the average number of cases occurring per 100 000 person 
each year or 100 000 persons per years.  
Crude incidence rate = 
Number of new cancer cases observed in the period (2004-2008) 
Total population in the period (2004-2008) 
 
 
 
 
  
38 
The calculation of this rate includes those cancers that had missing information about 
population group, sex, age. 
Age specific rate: -  
The adjusted rate for a specific age group. It is expressed as the rate of cases 
occurring in a specific age group per 100 000 persons. 
Age standardized (adjusted) rate (ASIR):- 
A weighed average of age specific cancer Incidence or mortality rates, in which the 
weights are the proportions of persons in the corresponding age group of a standard 
population. Using this rate permits comparison across populations with dissimilar age 
distribution. 
                                                       
Such that i represent each age group 
di: the number of cases in the ith age group 
yi: the population size in the ith age group  
wi: the weight applied for the ith age group 
di/yi being the age specific rate for each ith category  
With the sum of the wi being equal to 100 000 to express the ASIR per 100 000 
Persons-years. 
The standard worldwide population described by Segi (1960) and modified by Doll et 
al. (1966) was used for these calculations (Curado et al, 2007).   
 
Adjustment for age unknown 
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Adjustment has to be made for the proportion of people in the age unknown category. 
The formula is: ASR x (total cases / cases with known age). 
 
Calculation of variance of ASIR: 
The first step for calculation of standard error is to calculate the variances for each 
age-specific expected number of cases based on the world standard population, cases 
with un-known age are included.   
The second step is to sum all the age-specific variances. The variance for the age-
adjusted rate for cancer of the oral cavity (World standard population) is then 
determined as sum of all variances/100 000*100 000 
 
 
Cumulative rate and cumulative risk: -  
The cumulative cancer incidence rate can be used to calculate the cumulative life time 
risk (LR), that is, the probability of developing a cancer in one’s lifetime. The 
following formula was used: 
 
Such that i=5 year age group 
di: the number of cases in the ith age group 
yi: the population size in the ith age group  
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4.8 Ethical considerations: 
• The research proposal was submitted to the Faculty of dentistry, University of 
the Western Cape research committee for approval of the study. 
• Permission was obtained from KDTH to get patients records for this study. 
• Patient’s confidentiality was strictly preserved with no names, addresses or 
contact details being divulged. 
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CHAPTER 5 
5. RESULTS 
During the five year study period (2004-2008), 649 cases of maxillofacial 
malignancies were registered in Khartoum Dental Teaching Hospital (KDTH). These 
included, intraoral and lip cancer, maxillary sinus and major salivary gland 
malignancies. Out of the total number of reported cases (458), 71 % were intraoral 
neoplasms (Table 2). The average male: female ratio for intraoral neoplasms was 3: 2. 
The average annual number of reported intraoral cancer cases was 92 cases, with 72 
cases per year for males and 50 cases for females. There was a gradual annual 
increase in the total number of reported cases as depicted in Table 1 and Figure 1. The 
least number of cases were reported in 2004 (86 cases), and the highest number of 
cases were reported in 2008 (162 cases). Cases diagnosed as squamous cell carcinoma 
(SCC) constituted 72% of the total malignancies reported and 81% of intraoral 
malignancies. 4% of the registered cases were verrucous carcinomas (VC); 6% were 
sarcomas; and 4% were lymphomas (Figure 2). Lip cancer constituted 5.3% (35 
cases) of the total number of the cases reported. Salivary gland tumours were the 
second most prevalent malignancies, constituting 13% of the total malignancies 
reported, of which major salivary glands contributed 5% (Figure 2). Cases diagnosed 
as VC showed a striking predilection for males with a 3.25: 1, male to female ratio. 
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Table 1.Total number of reported cases of intraoral, lip, major salivary glands 
and maxillary sinus malignancies recorded per year: 
 2004 2005 2006 2007 2008 (2004-2008) 
Males 50 64 92 96 94 396 
Females 36 42 62 45 68 253 
Total 86 106 154 141 162 649 
 
Table 2. Distribution of the total cases reported in the period of the study for 
males and females 
Total number of cancer cases 
reported (2004-2008) F M Total 
Bone 14 16 30 
Major salivary gland 14 16 30 
Maxillary sinus 17 40 57 
Intraoral cancer 183 275 458 
lip cancer 9 26 35 
Others 16 23 39 
Total 253 396 649 
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Figure 2. Bar graph depicting the frequency of distribution of all malignancies for the 5 
years 
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Figure 3.  Bar graph depicting the pattern of all oral maxillofacial malignancies 
reported during the 5 year period of the study 
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Figure 4. Bar graph depicting the site distribution of the total oral and 
maxillofacial malignancies reported during the study period 
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5.1 Age distribution: 
The study population was estimated as 26.3 million in the mid-year of the study 
(2006). The distribution of the population follows the normal pattern with a broad 
base and a narrow top (Figure 5). There is a slight increase in the number of males 
compared to females but the ratio is almost consistent throughout the 5 year age 
distribution. 
4000 3000 2000 1000 0 1000 2000 3000 4000
0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
A
ge
 g
ro
up
s
Population in 1000
Male Female  
Figure 5: The age distribution for Sudanese males and females for the year 2006 
In the population under study the highest number of reported cases was observed 
above the age of 75 years. However, there was a sharp increase in the number of 
reported cases at the age of 40-44 years, with a gradual increase in the number of 
reported cases thereafter (Figure 6). The prevalence of OSCC above the age of 50 
years was 79% and 76% for males and females respectively (Figures 7 and 8).  
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Figure 6. The age of distribution of all malignancy cases reported during the 
study period 
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Figure 7. Age distribution of intraoral malignancy for males for the five years 
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Figure 8. Age distribution of intraoral malignancy for females for the five years 
 
5.2 Site distribution 
During the 5 year study period, an average of 69.77% (344 cases) of the total oral 
malignancies involved more than one anatomic site. This constituted 72.4% in males 
and 65.6% in females (M: F= 1.1: 1). The tongue was the second most common site 
of neoplastic involvement (10%; 59 cases), followed by the lip (6%; 35 cases) 
(Figures 9 and 4). Tongue malignancies approximately showed equal distribution 
between males and females. However, intraoral malignancies involving more than one 
anatomic site had a male predilection with male-to-female ratio of 1.7:1, while lip 
cancer showed a higher prevalence in males; male-to-female ratio was 2.89: 1. 
Maxillary sinus malignancies showed a male predilection with a 2: 1 ratio for males, 
while malignancies of salivary glands showed equal gender distribution (Figure 10). 
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Figure 9. Site distribution of oral & lip malignancies reported during the 5 year 
study period for males and females 
 
Figure 10. Bar graph depicting site distribution of maxillary sinus, salivary 
glands and bone malignancies by gender and male to female ratio 
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5.3 Geographical distribution and referral of cases 
The geographical distribution of the cases reported during the five year study period is 
shown in figure 12. 28% of the cases reported were from Khartoum state. While cases 
from the eastern and the northern states collectively contributed to 21% each of the 
total cases. 15% of the reported cases were from Gezira state only. Less cases have 
been reported from the western and southern states collectively (Figure 11).  
 
Figure 11. Depicts the geographical distribution of the reported cases in KDTH 
over the 5 years. 
 
The majority of the cases (303 cases, 47%) were not referred. 37% of cases were 
referred from other govermental hospitals. The major referring units included Ear 
Nose and Throat units (ENT), Dermatology, Internal Medicine and Surgery. A few 
cases were also referred from Neurosurgery, Physiotherapy, Radiotherapy and 
Paediatrics (Figure 12). 
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Figure 12: Depicts the referral process of all the cases presented at KDTH 
 
5.4 Incidence rates 
5.4.1 Age specific rates 
All states combined: 
The specific morbidity rate for (OSCC), including (VC) ranged from 0.00 to 46.58 per 
100 000 per year for males and 0.00 to 22.75 per 100 000 for females. That peak age 
specific rate was observed at the age of 75+ for both genders (Figures 13 & 14).  In 
females a smaller peak was also noted at 60-69 years; this peak was less noticeable in 
males. The age specific morbidity rate started increasing gradually at 35-39 years in 
females, while in males the increase was noted at the age of 40-44 years. 
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Figure 13: Line graph with trend showing age specific morbidity rate per 100 
000 per year for OSCC in males 
 
 
Figure 14: Line graph with trend showing age specific morbidity rate per 100 
000 per year for OSCC in females 
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Figure 15: Line graph with trend showing age specific morbidity rate per 100 
000 per year for oral & lip SCC in males 
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Figure 16: Line graph with trend showing age specific morbidity rate per 100 
000 per year for oral & lip SCC in females 
 
 
 
 
 
  
53 
Khartoum and Gezira States incidence rates 
Combined data from Khartoum and Gezira states revealed an age specific incidence 
rate for OSCC ranging from 0.00 to 32.47 per 100 000 for males and 0.00 to 20.00 for 
females.  The peak age specific rate was 75+ for females and 65-69 years for males. 
For oral & lip SCC, the age specific rate for males ranged from 0.00 to 40.26 per 100 
000 and 0.00 to 20.00 for females. Lip cancer was not contributing to oral cancer 
incidence in females. 
ASIR for OSCC was 3.34 and 2.02 per 100 000, while for oral & lip it was 3.74 and 
2.28 per 100 000 for males and females respectively. 
 
Figure 17: Age specific incidence rate with trend for OSCC for males in 
Khartoum and Gezira states 
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Figure 18: Age specific incidence rate with trend for OSCC for females in 
Khartoum and Gezira states 
 
 
Figure 19: Age specific incidence rate with trend for oral & lip SCC for males in 
Khartoum and Gezira states 
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Figure 20: Age specific incidence rate with trend for oral & lip SCC for females 
in Khartoum and Gezira states 
5.4.2 Age adjusted incidence rates 
Sudanese states combined: 
Table 3 shows the age adjusted incidence rate per 100 000 and the 95% confidence 
intervals (CI) of oral cancer for males and females. The adjusted age standardized 
incidence rates (ASIR) for oral & lip cancer over the study period were higher in 
males compared to females. The ASIRs for (OSCC/VC) was 3.19 for males and 1.83 
for females (M: F =1.74:1). The ASIRs of combined oral & lip SCC/VC in Sudanese 
males was 3.45 and 1.88 for females (M: F=1.84:1). Lip cancer is contributing very 
little to the incidence of oral cancer in the Sudan and it occurs mainly in males. The 
ASIR of lip cancer in males was 0.30 and in females it was 0.00 per 100 000. Total 
intraoral malignancies showed ASIRs of 3.48 for males and 2.12 females.  
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Table 3: Age adjusted incidence rate per 100 000/ year for oral cancer in males 
and females in Sudan 
 Lip Oral SCC 
Combined Oral 
and Lip SCC 
Oral 
malignancies 
Males 
0.30 
(CI: 0.15- 0.37) 
3.19 
(CI: 2.78-3.6) 
3.45 
(CI: 3.02-3.88) 
3.48  
(CI: 3.14-
3.8) 
Females 0.00  
1.83 
(CI: 1.52-2.14) 
1.88 
(CI:  1.57- 2.19) 
2.12 
(CI: 1.79-
2.24) 
 
Khartoum and Gezira States: 
Cases from Khartoum and Gezira revealed 13% higher (4.21) ASIR for OSCC/VC in 
males and 11% higher (2.09) for females than the corresponding estimates for the 
whole country. Similarly combined oral and lip SCC/VC was 11% higher (4.18) in 
males and 10% higher (2.28) in females, compared to their equivalent estimates of the 
whole country ( Table 3 and Table 4). 
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Table 4: Age adjusted incidence rate per 100 000/ year for oral cancer in males 
and females in Khartoum and Gezira states 
 Oral SCC Combined Oral and Lip SCC 
Males 
4.21  
(CI: 3.51-4.91) 
4.18 
 (CI: 3.51- 4.97) 
Females 
2.09  
(CI: 1.54- 2.64) 
2.28  
(CI: 2.28-2.28) 
 
5.5 95% Confidence intervals: 
Figures 21- 25 show the ASIRs and the higher (hi) and lower (lo) limits of the 95% 
confidence interval for OSCC/VC, oral & lip SCC/VC and oral malignancies for both 
males and females. 
 
 
 
 
 
  
58 
 
Figure 21: Depicts the ASIR per 100 000 of OSCC/VC for males and females in 
the Sudanese population 
  
 
Figure 22: Depicts the ASIR per 100 000 of oral & lip SCC/VC for males and 
females in the Sudanese population 
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Figure 23: Depicts the ASIR per 100 000 of OSCC/VC for males and females in 
the Khartoum and Gezira states 
 
Figure 24: Depicts the ASIR per 100 000 of oral & lip SCC/VC for males and 
females in the Khartoum and Gezira states 
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Figure 25: Depicts ASIR per 100 000 of all oral malignancies and 95% for 
Sudanese males and females 
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5.6 Cumulative risk and cumulative rate:  
Table 5: Depicts the cumulative risk (0-74) of developing oral cancer for 
Sudanese males and females 
 Lip Oral SCC 
Combined Oral &  
Lip SCC 
Oral 
malignancies 
Males 1:438 1: 181 1: 182 1: 429 
Females - 1: 344 1: 831 1: 819 
 
 
Table 6: Depicts the cumulative risk (0-74) of developing oral / oral & lip SCC in 
Khartoum and Gezira (combined), for males and females  
 Oral SCC Combined Oral & Lip SCC 
Males 1: 616 1: 497 
Females 1: 1000 1: 1000 
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CHAPTER 6 
6. DISCUSSION 
Based on data from Radiation and Isotope Centre Khartoum (RICK) in Sudan; Oral 
cancer was one of the 10 most common cancers in males and females during the 
period (1967-1984), while during the period (1985-2004), this cancer was not one of 
the most prevalent 10 cancers in the country (Hamad, 2006).  
For the total Sudanese population in 2006 of 36.3 million, 649 oral and maxillofacial 
(OMF) malignancies (M: F=1.44:1) were captured at KDTH during the 5-year period 
(2004-2008); 71% (458 cases) were intraoral malignancies; 497 cases were SCC/VC 
of which 390 (M: F=1.67:1) were (intra) oral squamous cancers (OSCC) and 
verrucous carcinomas (VC); 9% were maxillary sinus tumours (57 cases; M: F= 
2.35:1); 5% (30 cases; M: F= 1.14:1) were bone tumours; 5% (30 cases; 1.14:1) were 
major salivary gland malignancies; 5% (35 cases; M: F= 2.88:1) lip malignancies; and 
6% (39 cases; M: F= 1.44:1) were others. The latter group included lymphomas, 
sarcomas and malignant melanomas in addition to infrequent odontogenic 
malignancies.  
Squamous cell carcinoma/verrucous carcinoma (SCC/VC) were the most prevalent 
intraoral and lip malignancies, accounting for 86% in both males and females. The 
ratio of oral & lip SCC/VC compared to non-SCC was 11.2: 1 (248 cases: 22 cases), 
and 31: 1(155 cases: 5 cases) for males and females respectively. 
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6.1 Age distribution 
The age distribution of all malignancy cases during the five years revealed a gradual 
increase in the number of cases each decade in males and females. The average 
median age at diagnosis for all malignancies was 56 years for both genders and 81% 
of malignancy cases occurred after the age of 40. These results conform to the global 
epidemiology data (Warnakulasuriya, 2009) and are consistent with results of 
previous studies in Sudan (Osman et al, 2010; Idris et al, 1995(b)).  
Oral and lip squamous cell carcinoma showed an age range from 10 to 96 years with 
69.5% occurring after the age of 50 years. Lack of an increased incidence of oral 
cancer in ages younger than 50 years could imply lack of association of Human 
Papilloma Virus (HPV) in the study population. However, this is beyond the scope of 
the current study and further studies are needed to investigate this link. Lymphomas 
and sarcomas were more prevalent in ages younger than 50 years.  
A sharp increase in OSCC cases in males was seen in the age group 40-44 years with 
a gradual increase in the number of reported cases thereafter, peaking at the eighth 
decade. This pattern is consistent with the distribution of the population pyramid of 
the mid-year of the study period. Females showed a 5 year earlier onset of OSCC 
compared to males. The age group 35-39 years was the period of increased oral 
cancer incidence with a gradual subsequent rise in the number of reported cases until 
peaking at the eighth decade.  
SCC/VC of the lip presented over a wide age range varying from 13-80 years. 83% 
(25 cases) involved patients older than 50 years.  
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6.2 Anatomic sites 
Malignancies involving intraoral sites collectively revealed an overall male 
predilection. Seventy five percent (344 cases) of intraoral SCC involved more than 
one anatomic site. This pattern was seen in both genders. This could reflect the late 
presentation of most patients after the tumour reached a very large size. Delayed 
clinical presentation of patients with oral cancer was documented in previous studies 
(Osman et al, 2009). Illiteracy, ignorance, poverty and lack of awareness about oral 
cancer plus long travel distances are contributing factors to the late presentation of 
patients seeking medical treatment. Osman and colleagues suggested Toombak use 
could be one of the reasons for this pattern of distribution of OSCC in Sudanese 
(Osman et al, 2009). However, this pattern is also prevalent in females in which the 
habit is far less common. However, this conclusion may be jeopardized by the fact 
that this habit is regarded as a social stigma in the Sudanese community in general 
and in females in particular. More studies are needed to investigate the reasons for the 
overwhelming predominance of this pattern and for the possible association with 
Toombak use.  
Tongue cancers were the second site of intraoral malignancies with equal distribution 
in males and females. The estimated rate of tongue cancer for both genders was found 
to be 11.96% of the total oral and lip malignancies. This is significantly lower than 
the rate reported in the United States, which constituted 40-50% of oral cancers 
(Warnakulasuriya, 2009). Lifestyle and differences in risk factors involved could 
explain this difference in the low prevalence of tongue cancer in the Sudanese 
population.  
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Oral cancer involving the palate and the floor of mouth were the least common sites 
of intraoral cancer and showed equal gender distribution. The gum was also an 
uncommon site of intraoral cancer with increased prevalence in males with a male-to-
female ratio of 1.83: 1. The habit of Toombak dipping may explain this pattern, as 
Toombak is mainly used by males and the most common site of placement of the 
Toombak dip is the labial sulcus. 
 
SCC of the lip was generally uncommon. Our findings are consistent with other 
studies from Africa and Portugal (Monteiro et al, 2013; Kamulegeya and 
Kalyanyama, 2008; Marimo and Hille, 2006; Chidzonga and Mahomva, 2006). 
However, lip cancer prevalence showed a striking male prevalence with a M: F ratio 
of 2.89: 1. The habit of Toombak dipping in the lower labial sulcus in addition to 
sunlight damage associated with outdoor occupations, could be a reasonable 
explanation for the predominance of this cancer in males. It is also possible that some 
of the lip cancer patients presented at an advanced stage, specially cases referred from 
the rural regions and therefore the tumour was grouped as mouth NOS.  Also placing 
the Toombak kid at the labial sulcus could have contributed to cancer of the gingiva 
and not necessarily to cancers of the mucosal site of the lip. 
 
Malignancies involving the maxillary sinus constituted 10% of the total malignancies 
reported during the study period. The prevalence of these tumours showed a male-to-
female ratio of 2.35: 1.  
In line with previous studies published by Idris and colleagues (Idris et al, 1995(b)), 
salivary gland malignancies were the second most prevalent malignancies; accounted 
for 11% of the total malignant maxillofacial tumours and 5% of the intraoral 
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neoplasms with almost equal gender distribution (M: F= 1.14:1). Bone tumours 
constituted 5% of malignant cases reported with equal male and female distribution 
(M: F= 1.14:1). 
6.3 Incidence rates 
Calculation of the true incidence of oral cancer in Sudan is not possible unless a 
proper cancer registry is established in the future. Under-reporting of cancer cases in 
Sudan was a well-recognized phenomenon from previous studies (Hamad 2006, Idris 
et al, 1995). This research was aimed at establishing the minimum relative age 
standardised incidence rate of OSCC/VC for the Sudanese population during the five 
year study period. Data of new cancer cases reported during the period of the study 
was obtained from Khartoum Dental Teaching Hospital (KDTH). This still remains 
the main referral hospital in the country and the only hospital that offers management 
for oral cancer patients. Both private and governmental hospitals refer oral cancer 
cases to KDTH for management. Therefore in our study, due to the potential 
duplication of cases, no data was taken from other sources. It was also unlikely that 
oral cancer cases got treatment in other disciplines such as the ENT department as the 
maxillofacial surgeons perform all the oral cancer related surgeries. 
A well-established database system for registering all oral cancer cases was only 
established in late 2003. This system documented all histologically diagnosed oral 
cancer cases referred to KDTH. The system identifies the cases based on a file 
number. The referring hospitals/ units and the region/ state from which the cases 
referred were all documented, although in some cases the regional distribution lacks 
proper district description which could confound the analysis of incidence data.  
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Therefore, data presented in this research represents the minimum oral cancer 
incidence documented in the main referral hospital of Sudan. As mentioned earlier 
under-reporting has to be acknowledged, unless a population based cancer registry is 
established.  
Although most of the cancer registries indicate a drop of cancer incidence in the 
elderly, the age specific morbidity rate graphs presented in this project (Fig.13-20) 
reflected a steady rise at the age of 75+. This remark could be attributed to the fact 
that the age group 75+ constituted a relatively large proportion of the cancer cases.  
No breakdown of the age group 75+ was further done since the population specific 
data obtained from the population census that was used to calculate ASIR was 
designated up to 75+.   
We compared our results to GLOBOCAN 2008 on oral and lip cancer, as these results 
are in line with the period of our study and with the same population data statistics 
(GLOBOCAN, 2008). Our final access to GLOBOCAN, 2008 was in November 
2013. The data was subsequently updated to GLOBOCAN, 2012 and GLOBOCAN, 
2008 is no longer accessible. The major change in Sudan GLOBOCAN, 2012 was 
that the original Sudan was split into two countries Sudan and South Sudan. Therefore 
the population statistics in GLOBOCAN, 2012 is different for Sudan after the 
political separation (GLOBOCAN, 2012). 
The ASIRs of combined oral & lip SCC/VC in Sudanese males was 3.45 and 1.88 for 
females (M: F=1.84:1). These compare relatively well with the GLOBOCAN data 
which estimates a slightly lower ASIR of 3.3 for males and somewhat higher ASIR of 
2.1 for females (M: F=1.57:1) (GLOBOCAN, 2008). 
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We also estimated ASIR for males and females for cases from Khartoum and Gezira 
states. These are the biggest states in Sudan with the highest population density and 
the closest areas to KDTH. Cases from Khartoum and Gezira revealed 13% higher 
(4.21) ASIR for OSCC/VC in males and 11% higher (2.09) for females than the 
corresponding estimates for the whole country. Similarly combined oral and lip 
SCC/VC is 11% higher (4.18) in males and 10% higher (2.28) in females, compared 
to their equivalent estimates of the whole country. 
GLOBOCAN, 2012 ASIR estimates for oral and lip cancer were 4% (3.7) higher for 
males than the 2008 estimates, while the rates in females were only 2% (2.3) higher 
than the corresponding 2008 estimates. However, there appeared to be neither a clear 
evidence of the source nor the regional distribution of oral cancer cases in 
GLOBOCAN, 2012 and 2008 (GLOBOCAN, 2008; GLOBOCAN, 2012). 
Table 7: Comparison of the estimated ASIR from GLOBOCAN and KDTH: 
 Lip Oral SCC Combined Oral and 
Lip SCC 
Oral malignancies 
Males 
0.30 
(CI: 0.15- 0.37) 
3.19 
(CI: 2.78-3.6) 
3.45 
(CI: 3.02-3.88) 
3.48 
(CI: 3.14-3.8) 
Females 0.00 
1.83 
(CI: 1.52-2.14) 
1.88 
(CI:  1.57- 2.19) 
2.12 
(CI: 1.79-2.24) 
GLOBOCAN 
2008 
- - 
Males: 3.3 
Females: 2.1 
- 
GLOBOCAN 
2012 
- - 
Males: 3.7 
Females: 2.3 
- 
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These figures highlight that the population denominators and the regional distribution 
of cases could impact on the incidence estimates. The assumption that all cancer cases 
came from the different regions of the country equally may not reflect and describe 
the actual burden of the disease, especially in a country like Sudan that depends on a 
main referral hospital located in the capital. It was predicted in previous literature that 
some patients with oral cancer from the rural areas may die of the disease before 
reaching the referral hospital. This is further complicated by the erroneous perception 
that oral cancer is an infectious disease and people regard it as a social stigma. In 
addition to that many patients especially from the rural areas prefer to present to 
traditional healers rather than seeking medical care in hospitals.  
Consideration of the regional distribution of data could also aid in tracking referral 
bias more precisely, in addition to having a clear picture of the distribution and the 
burden of oral cancer in the country, which may be influenced by environmental and 
climatic variety, ethnic variation or risk factors. This also alerts the government to 
health care intervention in problematic states or regions. 
The ASIRs for oral and lip cancer derived from GLOBOCAN 2012 were consistently 
higher for males, females and both sexes combined in South Sudan compared to 
Sudan. The reason for the high estimates in South Sudan could be ascribed to the 
small population size, or reduced referral of oral cancer cases to Khartoum during the 
period of the study; the later is very plausible as the distance from Khartoum to Juba 
(Capital of South Sudan) is 1209.1 Kilometres, in addition to the conditions of the war 
which also could have been a contributing factor to diminish referral.  
Sudan ASIR estimates for both males and females were slightly higher compared to 
other Northern African countries such as Egypt and Morocco (GLOBOCAN 2012). 
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The habit of Toombak dipping in the Sudanese population, especially males could 
explain this increase; however studies on risk factors of oral cancer in these countries 
could be beneficial to elucidate differences.  
Compared to other African countries, Sudan’s ASIR estimates for oral and lip cancer 
were in the mid of the curve. Countries such as Botswana and Mauritius have 
relatively high male ASIRs of oral and lip cancer, estimated as 8.8 and 7.4 
respectively. Interestingly the two countries have strikingly lower estimates for 
females; 2.0 and 3.2 for Botswana and Mauritius respectively. Although a general 
trend of reduced ASIR estimates for female was evident in all the African countries 
(GLOBOCAN 2012). Unfortunately comparison of GLOBOCAN 2008 and our 
estimates was difficult to attain from the GLOBOCAN website. 
Analysis of the geographical distribution of the cases recorded in KDTH revealed that 
only 5% of the cases originated from the South, compared to 28% from Khartoum 
state, 15% from Gezira state, 21% from the Eastern states collectively, 21% from 
Northern states collectively, and 9% from the Western region (Fig.11). The decrease 
in oral cancer reported from some of these regions could reflect difficulty of patients 
attending dental care units, as the majority of the cases were from either Khartoum 
state or neighbouring regions. However other indigenous factors that contributed to 
oral cancer in some of the districts were also plausible; e.g. the Northern state 
although far from the centre, a large percentage of cases were derived from that 
region. Toombak dipping is also viewed as a popular habit in males from the Northern 
states. The 5% of the cases from the South were probably the Southern Sudanese that 
live in the North.  
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6.4 Cumulative risk (0-74) 
In general the estimated cumulative risks (CR) of developing oral & lip SCC/VC 
during a lifetime (0-74 years) were very low for both males and females (Table 5, 6; 
Appendix 7, 8). Lip SCC/VC has a very small impact on the CR of oral & lip 
SCC/VC for males, while the CR of oral & lip SCC/VC in females is markedly 
affected by lip cancer. Females showed markedly increased CR of oral cancer, when 
lip cancer was excluded from the calculation.  
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CHAPTER 7 
7. CONCLUSION AND RECOMMENDATIONS 
Oral cancer incidence data vary according to socio-political, environmental, illiteracy, 
lack of awareness and documentation factors. Careful interpretation of the data 
including the source, the exact characterization and the regional distribution could 
impact on the analysis. Cautious interpretation of GLOBOCAN data is required when 
used in healthcare planning.  
Our study provides evidence that Sudan has a high relative ASIR for oral cavity and 
lip cancer. These incidence rate figures are higher than incidence rates reported in 
other African countries (Curado et al, 2007). There is great need for the establishment 
of a pathology-based national cancer registry in Sudan that ensures accurate 
documentation of cancer cases. A good way to start could be linking the different 
hospitals with a computer network that enables the documentation and registration of 
all oral cancer cases. There is also a need to increase dental care facilities in the 
peripheral areas outside the capital city to facilitate early detection and therefore 
decrease the burden of the disease and prevent waste of resources. 
This project also highlighted that proper description of the denominators in 
calculation of ASIR estimates could impact significantly on interpretation of the 
estimates. We therefore advocate considering the regional distribution of oral cancer 
when estimating ASIR data whenever feasible. 
Future follow up studies for site specific incidence rates are necessary to establish 
trends of oral cancer in Sudanese patients. More studies are needed to investigate the 
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reasons for the overwhelming preponderance of oral cancer cases involving more than 
one anatomic site. 
A significant difference in oral ASIR was observed between males and females. Oral 
health promotion and awareness programmes regarding the risk factors, clinical 
presentation and signs of oral cancer are needed especially in the peripheral and rural 
areas. The programmes should include basic education campaigns and radio and 
television awareness. Introduction of oral examination as part of the general 
examination could also aid in early detection of oral cancer and therefore more 
effective and less costly treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
74 
CHAPTER 8 
8. LIMITATION OF THE STUDY 
The time period of the study was confounded by the time when the proper database in 
KDTH was established and the country planning and making arrangements to 
separate into two countries; Sudan and South Sudan. Studies over longer duration are 
more helpful in establishing trends and changes in the epidemiology of oral cancer. 
 
The data obtained in this study was the minimum number of documented cases of oral 
and lip cancer in the country. The true incidence rate of oral and lip cancer cannot be 
precisely calculated since there is no proper cancer registry in Sudan. The aim of this 
project was to bring to light the burden of the problem of oral cancer and to convey to 
the attention of the government the need and necessity for health care intervention to 
increase public awareness about oral cancer and risk factors especially in rural areas. 
 
Reporting of age standardized incidence rates (ASIRs) for intraoral cancer sites 
combined could be misleading. e.g. in our case oral cancer involving more than one 
anatomic sites showed the highest prevalence, while cancer involving this distribution 
is less common in most other population groups. Future site specific ASIRs are 
required to investigate differences in distribution patterns for the different intraoral 
sites, which facilitate discovery of changes in oral cancer trends over the years as well 
as comparison to global data. 
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APPENDICES 
Appendix 1: Ethics clearance certificate: 
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Appendix 2: ICD-10 Nomenclature of oral cavity topography 
Malignant neoplasms of the lip, oral cavity and pharynx (C00-C14) 
C00 Malignant neoplasm of lip 
 Excludes: skin of lip 
C00.0 External upper lip 
 Upper lip: 
 NOS 
 Lipstick area 
 Vermilion border 
C00.1 External lower lip 
 Lower lip: 
 NOS 
 Lipstick area 
 Vermilion border 
C00.2 External lip, unspecified 
 Vermilion border NOS 
C00.3 Upper lip, inner aspect 
 Upper lip: 
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 Buccal aspect 
 Frenulum 
 Mucosa 
 Oral aspect 
C00.4 Lower lip 
 Lower lip: 
 Buccal aspect 
 Frenulum 
 Mucosa 
 Oral aspect 
C00.5 Lip, unspecified, inner aspect 
 Lip, not specified whether upper or lower: 
 Buccal aspect 
 Frenulum 
 Mucosa 
 Oral aspect 
C00.6 Commisure of lip 
C00.8 Overlapping lesion of lip 
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C00.9 Lip, unspecified 
C01 Malignant neoplasm of base of tongue 
 Dorsal surface of base of tongue 
 Fixed part of tongue NOS 
 Posterior third of tongue 
C02 Malignant neoplasm of other and unspecified parts of tongue 
C02.0 Dorsal surface of tongue 
 Anterior two-thirds of tongue, dorsal surface 
 Excludes: dorsal surface of base of tongue 
C02.1 Border of tongue 
 Tip of tongue 
C02.2 Ventral surface of tongue 
 Anterior two-thirds of tongue, ventral surface 
 Frenulum linguae 
C02.3 Anterior two-thirds of tongue, part unspecified 
 Middle third of tongue NOS 
 Mobile part of tongue NOS 
C02.4 Lingual tonsil 
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 Excludes: tonsil NOS 
C02.8 Overlapping lesion of tongue 
Malignant neoplasm of tongue whose point of origin cannot be classified to 
any one of the categories C01-C02.4 
C02.9 Tongue, unspecified 
C03 Malignant neoplasm of gum 
 Includes: alveolar (ridge) mucosa, gingival 
 Excludes: malignant odontogenic neoplasms 
C03.0 Upper gum 
C03.1 Lower gum 
C03.9 Gum, unspecified 
C04 Malignant neoplasm of floor of mouth 
C04.0 Anterior floor of mouth 
 Anterior to the premolar-canine junction 
C04.1 Lateral floor of mouth 
C04.8 Overlapping lesion of floor of mouth 
C04.9 Floor of mouth, unspecified 
C05 Malignant neoplasm of palate 
C05.0 Hard palate 
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C05.1 Soft palate 
 Excludes: nasopharyngeal surface of soft palate 
C05.2 Uvula 
C05.8 Overlapping lesion of palate 
C05.9 Palate, unspecified 
 Roof of mouth 
C06 Malignant neoplasm of other and unspecified parts of mouth 
C06.0 Cheek mucosa 
 Buccal mucosa NOS 
 Internal cheek 
C06.1 Vestibule of mouth 
 Buccal sulcus (upper) (lower) 
 Labial sulcus (upper) (lower) 
C06.2 Retromolar area 
C06.8 Overlapping lesion of other and unspecified parts of mouth 
C06.9 Mouth, unspecified 
Minor salivary gland, unspecified site 
 Oral cavity NO 
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Appendix 3: An abstract from the raw data recorded in KDTH: 
Folder 
2004 
Year 
report
ed 
Gender Age ICD Ca code Diagnosis Occupation 
Medical 
supervisor 
State Refferal hospital Tribe 
502 2004 M 55 C06.9 Mouth Squamous cell carcinoma NOS paramedical ب /دﻣﺣا نﺎﻣﯾﻠﺳ gezira private clinic ﺔﻠھاوﻛ 
318 2004 M 38 C06.9 Mouth  Squamous cell carcinoma NOS Driver ب/دﻣﺣا نﺎﻣﯾﻠﺳ Khartoum not reffered ﺔﯾﻧﺎﺳﺣ 
818 2004 M 68 C06.9 Mouth  Squamous cell carcinoma NOS Farmer ب/دﻣﺣا نﺎﻣﯾﻠﺳ Khartoum not reffered ﻻ دﺟوﯾ 
1320 2004 M 66 C06.9 Mouth  Squamous cell carcinoma NOS pensioner ب/ﺣادﻣ نﺎﻣﯾﻠﺳ Khartoum not reffered ﻲﻘﯾﺎﺷ 
725 2004 F 50 C08.0  acinic cell carcinoma  house wife ب/دﻣﺣا نﺎﻣﯾﻠﺳ White Nile not reffered ﺔﻠھاوﻛ 
1626 2004 F 32 C06.9 Mouth  Squamous cell carcinoma NOS house wife ب/دﻣﺣا نﺎﻣﯾﻠﺳ North  gov. hospital شﯾﺑﺎﺑﻛ 
826 2004 M 5 C06.0 Mouth rhabdomyosarcoma child ب/دﻣﺣا نﺎﻣﯾﻠﺳ gezira gov. hospital ﺔﯾﻧﺎﺳﺣ 
730 2004 M 43 C06.9 Mouth  Squamous cell carcinoma NOS Farmer ب/دﻣﺣا نﺎﻣﯾﻠﺳ Khartoum not reffered ﻰﺗﻼﻓ 
1330 2004 F 45 C41.8  osteosarcoma off work ب/دﻣﺣا نﺎﻣﯾﻠﺳ North  not reffered ﻻ دﺟوﯾ 
1333 2004 F 79 C06.1 Mouth Squamous cell carcinoma house wife ب/دﻣﺣا نﺎﻣﯾﻠﺳ River Nile not reffered ﻻ دﺟوﯾ 
635 2004 F 73 C31.0  squamous cell carcinoma  off work م/فﺳوﯾ نﺎﻣﺛﻋ Khartoum not reffered روﻓ 
741 2004 F 40 C06.8 Mouth adenocarcinoma house wife ب/دﻣﺣا نﺎﻣﯾﻠﺳ Khartoum not reffered ﺔﺑوﻧ 
441 2004 F 38 C02.8 Tongue Squamous cell carcinoma off work ب/دﻣﺣا نﺎﻣﯾﻠﺳ Khartoum private clinic ﺔﯾرﯾدﺑ 
331 2004 M 44 C06.9 Mouth  Squamous cell carcinoma NOS business  ب/دﻣﺣا نﺎﻣﯾﻠﺳ Khartoum private clinic ﻲﻠﻌﺟ 
759 2004 M 68 C06.9 Mouth  Squamous cell carcinoma NOS pensioner ب/دﻣﺣا نﺎﻣﯾﻠﺳ gezira not reffered يوﻼﻘﻧد 
491 2004 M 66 C06.8 Mouth Squamous cell carcinoma Farmer ب/دﻣﺣا نﺎﻣﯾﻠﺳ Khartoum not reffered ةدﻣﺎﺣا 
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1423 2004 M 49 C06.8 Mouth Squamous cell carcinoma laborer ب/دﻣﺣا نﺎﻣﯾﻠﺳ Khartoum not reffered ﺔﯾﻋوﻣﺟ 
509 2004 F 73 C06.1 Mouth Squamous cell carcinoma house wife م /رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ Khartoum private clinic ﻲﺳﺣﻣ 
142 2004 M 43 C31.0  squamous cell carcinoma  house wife م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ Khartoum private clinic ﺔﯾﻧﺎﺳﺣ 
143 2004 M 73 C06.9 Mouth Squamous cell carcinoma NOS business  م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ gezira not reffered ﻻ دﺟوﯾ 
648 2004 M 45 C06.1 Mouth anaplastic carcinoma laborer م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ River Nile gov. hospital ﺑرﻲﺑﺎطﺎ 
149 2004 M 19 C41.1  osteosarcoma student م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ Khartoum not reffered ﺔﯾرﯾﺳﻣ 
150 2004 M   C31.0  squamous cell carcinoma  house wife م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ Blue Nile not reffered ﺎﻣﺎﺗ 
854 2004 M 25 C07 parotid mucoepidermoid carcinoma Driver م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ Khartoum not reffered تﯾﻟﺎﺳﻣ 
654 2004 M 65 C02.9 Tongue Squamous cell carcinoma NOS Farmer م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ gezira not reffered ﮫﯾرﻛﺷ 
360 2004 M 58 C05.8 palate mucoepidermoid carcinoma Farmer م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ South  not reffered ﻻ دﺟوﯾ 
161 2004 M 77 C06.9 Mouth  Squamous cell carcinoma NOS Farmer م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ Gedarif gov. hospital فارﺷا 
173 2004 F 63 C05.8 palate Squamous cell carcinoma house wife م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ North  gov. hospital شﯾﺑﺎﺑﻛ 
176 2004 M 68 C06.0 Mouth Squamous cell carcinoma off work م/رﺻﺎﻧﻟادﺑﻋ رﻔﻌﺟ River Nile gov. hospital ﻲﻠﻌﺟ 
540 2004 F 61 C06.9 Mouth  Squamous cell carcinoma NOS house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered ﻲﻘﯾﺎﺷ 
1101 2004 M 71 C06.9 Mouth  Squamous cell carcinoma NOS laborer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum E.N.T يودﻧدھ 
601 2004 F 66 C06.9 Mouth  Squamous cell carcinoma NOS house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered ﻲﻘﯾﺎﺷ 
716 2004 M 72 C04.8 floor of 
mouth 
Squamous cell carcinoma Farmer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered دﺑﺔﯾرﯾ 
519 2004 M 68 C06.9 Mouth  Squamous cell carcinoma NOS pensioner م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ River Nile not reffered ﻲﻠﻌﺟ 
1526 2004 F 70 C02.8 Tongue Squamous cell carcinoma house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered ةرﻓﺎﻌﺟ 
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528 2004 F 58 C06.9 Mouth  Squamous cell carcinoma NOS house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered ﺔﯾرﯾﺳﻣ 
530 2004 F 79 C06.0 Mouth Squamous cell carcinoma house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Northern not reffered ﻲﻘﯾﺎﺷ 
431 2004 F 41 C06.8 Mouth Squamous cell carcinoma off work م/ادﺑﻋلﺎﻌﻟ دﻣﺣﻣ Khartoum not reffered ﻲﻠﻌﺟ 
435 2004 M 63 C06.9 Mouth Verrucous carcinoma NOS laborer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum Dermatology ﺔﺑرﺎﻐﻣ 
542 2004 M 53 C06.9 Mouth Squamous cell carcinoma NOS Farmer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum gov. hospital ﺔﻌﻣاوﺟ 
847 2004 M 61 C00.8 Lip Squamous cell carcinoma Farmer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ White Nile not reffered ﻻ دﺟوﯾ 
1257 2004 F 83 C31.0  squamous cell carcinoma  house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered رﺟﻧﺗ 
462 2004 F 73 C06.9 Mouth  Squamous cell carcinoma NOS off work م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ gezira not reffered ﻲﻠﻌﺟ 
464 2004 F 63 C31.0  squamous cell carcinoma  house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Sennar not reffered ﻰﺗﻼﻓ 
1264 2004 F 73 C06.9 Mouth  Squamous cell carcinoma NOS house wife م /لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum private clinic فارﺷا 
465 2004 M 63 C06.9 Mouth  Squamous cell carcinoma NOS Farmer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ West  gov. hospital ﻻ دﺟوﯾ 
1266 2004 M 83 C02.8 Tongue verrucous carcinoma Farmer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered ﻲﺑﺎطﺎﺑر 
567 2004 M 73 C06.1 Mouth Squamous cell carcinoma Farmer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum gov. hospital دﻣﺎﺣراد 
568 2004 F 63 C07 parotid Squamous cell carcinoma off work م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ River Nile private clinic ةدﻣﺎﺣا 
671 2004 M 49 C06.9 Mouth Squamous cell carcinoma NOS business  م/ﻋلﺎﻌﻟادﺑ دﻣﺣﻣ Khartoum private clinic ةدﯾﺎﺷر 
1272 2004 M 61 C31.0  squamous cell carcinoma  not  م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered ﻻ دﺟوﯾ 
478 2004 F 43 C06.1 Mouth Squamous cell carcinoma house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ White Nile not reffered شﯾﺑﺎﺑﻛ 
681 2004 M 48 C96.9  lymphoma police man م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered ﻲﻠﻌﺟ 
481 2004 M 39 C06.9 Mouth Squamous cell carcinoma NOS Farmer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ River Nile not reffered ﻲﻠﻌﺟ 
583 2004 M 58 C04.9 floor of Squamous cell carcinoma NOS not  م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ gezira gov. hospital ﺔﻠھاوﻛ 
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483 2004 M 58 C31.0  squamous cell carcinoma  not  م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum Neurosurgery ﻻ دﺟوﯾ 
1284 2004 F 43 C06.8 Mouth verrucous carcinoma house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ gezira not reffered ﺎﻛﻧﯾد 
585 2004 M 41 C31.0  squamous cell carcinoma  laborer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ gezira gov. hospital ﻻ دﺟوﯾ 
592 2004 M 32 C41.1  osteosarcoma Farmer م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ gezira not reffered ﻲﺑﺎطﺎﺑر 
593 2004 M 75 C00.9 Lip Squamous cell carcinoma NOS pensioner م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum not reffered ﻲﻘﯾﺎﺷ 
5173 2004 F 48 C41.1  Squamous cell carcinoma house wife م/لﺎﻌﻟادﺑﻋ دﻣﺣﻣ Khartoum university ﻰﻧﺑ رﻣﺎﻋ 
515 2004 M 76 C06.9 Mouth Squamous cell carcinoma NOS shepherd م /نﺎﻣﺛﻋ يدﻧﺟﻟا River Nile private clinic ﻲﻠﻌﺟ 
415 2004 M 59 C07 parotid mucoepidermoid carcinoma Driver م /نﺎﻣﺛﻋ ىدﻧﺟﻟا Khartoum Radiotherapy ىوﺎﻔﻠﺣ 
1131 2004 M 48 C31.0  squamous cell carcinoma  Farmer م /نﺎﻣﺛﻋ يدﻧﺟﻟا North  gov. hospital ﻻ دﺟوﯾ 
436 2004 F 19 C41.0  adenocarcinoma house wife م /نﺎﻣﺛﻋ يدﻧﺟﻟا Sennar gov. hospital ﻻ دﺟوﯾ 
547 2004 F 73 C05.0 palate mucoepidermoid carcinoma Farmer م /نﺎﻣﺛﻋ يدﻧﺟﻟا Gedarif gov. hospital ىوﺎﺟاد 
1364 2004 M 68 C06.9 Mouth Squamous cell carcinoma NOS pensioner م /نﺎﻣﺛﻋ ىدﻧﺟﻟا gezira gov. hospital ﻲﻘﯾﺎﺷ 
1464 2004 F 47 C07 parotid Squamous cell carcinoma laborer م /نﺎﻣﺛﻋ ىدﻧﺟﻟا Kassala gov. hospital ﺔﯾﻋوﻣﺟ 
1467 2004 F 60 C00.8 Lip Squamous cell carcinoma laborer م /نﺎﻣﺛﻋ يدﻧﺟﻟا Khartoum gov. hospital ﻻ دﺟوﯾ 
1476 2004 F 53 C41.1  malignant fibrous histocytoma house wife م /نﺎﻣﺛﻋ ىدﻧﺟﻟا North  not reffered ﺔﯾﻧﺎﺳﺣ 
689 2004 M 67 C00.8 Lip Squamous cell carcinoma Engineer م /نﺎﻣﺛﻋ ىدﻧﺟﻟا Khartoum gov. hospital ﺔﺑرﺎﻐﻣ 
699 2004 F 26 C83.7  Burkitt`s lymphoma house wife م /نﺎﻣﺛﻋ ىدﻧﺟﻟا gezira not reffered ﻲﻠﻌﺟ 
303 2004 F 30 C06.9 Mouth  mucoepidermoid carcinoma NOS house wife م/لﯾﻧﻟا دﻣﺣا Northern not reffered ﻻ دﺟوﯾ 
312 2004 M 63 C02.8 Tongue Squamous cell carcinoma off work م/لﯾﻧﻟا دﻣﺣا River Nile not reffered زوﻧﻛ 
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235 2004 F 68 C06.9 Mouth Squamous cell carcinoma NOS house wife م/لﯾﻧﻟا دﻣﺣا Khartoum not reffered ﻻ دﺟوﯾ 
859 2004 M 63 C00.8 Lip Squamous cell carcinoma business  م/روﻧﻟا مﯾھارﺑا Khartoum Dermatology ﻻ دﺟوﯾ 
260 2004 M 6 C49.0  rhabdomyosarcoma child م/لﯾﻧﻟا دﻣﺣا gezira E.N.T ﺔﺑرﺎﻐﻣ 
264 2004 M 73 C06.9 Mouth Squamous cell carcinoma NOS shepherd م/روﻧﻟا مﯾھارﺑا West  not reffered ﺔﯾرﯾدﺑ 
379 2004 M 87 C06.9 Mouth Squamous cell carcinoma NOS Farmer م/روﻧﻟا مﯾھارﺑا gezira not reffered ﺔﻠھاوﻛ 
285 2004 F 48 C06.9 Mouth  Squamous cell carcinoma NOS house wife م/لﯾﻧﻟا دﻣﺣا North  not reffered ﺔﻌﻣاوﺟ 
297 2004 F 68 C00.1 Lip Squamous cell carcinoma not  م/لﯾﻧﻟا دﻣﺣا Khartoum not reffered شﯾﺑﺎﺑﻛ 
107 2004 M 72 C06.9 Mouth Squamous cell carcinoma NOS Farmer م/دﻣﺣﻣ ﻰﺳرﻣ Khartoum not reffered ﺔﻠھاوﻛ 
25 2004 F 8 C83.7  Burkitt`s lymphoma not  م/دﻣﺣﻣ ﻲﺳرﻣ Khartoum Radiotherapy ﮫﯾﻣﻠﺳﻣ 
42 2004 M 51 C08.9  adenoid cystic carcinoma NOS Farmer م/دﻣﺣﻣ ﻲﺳرﻣ North  private clinic ﻰﻣزﺎﺣ 
44 2004 F 35 C06.8 Mouth Squamous cell carcinoma house wife م/دﻣﺣﻣ ﻲﺳرﻣ Khartoum private clinic رﻣﺣ 
67 2004 F 63 C06.0 Mouth Squamous cell carcinoma house wife م/دﻣﺣﻣ ﻲﺳرﻣ gezira not reffered شﯾﺑﺎﺑﻛ 
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Appendix 4: Numbers of cases of intraoral squamous cell 
carcinoma, excluding lip cancer per age group per 
year for females 
 
Frequency 
Col Pct 
 
Table of age by year 
year 
age 
2004 2005 2006 2007 2008 Total 
10-14 
0 
0.00 
 
1 
3.33 
 
1 
1.85 
 
0 
0.00 
 
0 
0.00 
 
2 
  
 
15-19 
0 
0.00 
 
0 
0.00 
 
1 
1.85 
 
1 
3.57 
 
1 
2.04 
 
3 
  
 
20-24 
0 
0.00 
 
1 
3.33 
 
0 
0.00 
 
2 
7.14 
 
1 
2.04 
 
4 
  
 
25-29 
0 
0.00 
 
2 
6.67 
 
3 
5.56 
 
1 
3.57 
 
5 
10.20 
 
11 
  
 
30-34 2 1 0 1 2 6 
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9.09 
 
3.33 
 
0.00 
 
3.57 
 
4.08 
 
  
 
35-39 
2 
9.09 
 
3 
10.00 
 
4 
7.41 
 
0 
0.00 
 
6 
12.24 
 
15 
  
 
40-44 
4 
18.18 
 
4 
13.33 
 
1 
1.85 
 
2 
7.14 
 
4 
8.16 
 
15 
  
 
45-49 
1 
4.55 
 
0 
0.00 
 
6 
11.11 
 
2 
7.14 
 
3 
6.12 
 
12 
  
 
50-54 
0 
0.00 
 
7 
23.33 
 
2 
3.70 
 
5 
17.86 
 
5 
10.20 
 
19 
  
 
55-59 
1 
4.55 
 
3 
10.00 
 
6 
11.11 
 
4 
14.29 
 
1 
2.04 
 
15 
  
 
60-64 
3 
13.64 
 
3 
10.00 
 
7 
12.96 
 
4 
14.29 
 
10 
20.41 
 
27 
  
 
65-69 
2 
9.09 
 
2 
6.67 
 
4 
7.41 
 
1 
3.57 
 
1 
2.04 
 
10 
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70-74 
5 
22.73 
 
1 
3.33 
 
7 
12.96 
 
2 
7.14 
 
0 
0.00 
 
15 
  
 
75+ 
2 
9.09 
 
2 
6.67 
 
12 
22.22 
 
3 
10.71 
 
10 
20.41 
 
29 
  
 
Total 22 
 
30 
 
54 
 
28 
 
49 
 
183 
  
  
Appendix 5: Numbers of cases of lip squamous cell carcinoma, per 
age group per year for males 
Frequency 
Col Pct 
 
Table of age by year 
year 
age 
2004 2006 2007 2008 Total 
10-14 
0 
0.00 
 
1 
14.29 
 
1 
9.09 
 
0 
0.00 
 
2 
  
 
25-29 
0 
0.00 
 
1 
14.29 
 
0 
0.00 
 
0 
0.00 
 
1 
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35-39 
0 
0.00 
 
1 
14.29 
 
0 
0.00 
 
0 
0.00 
 
1 
  
 
40-44 
0 
0.00 
 
1 
14.29 
 
0 
0.00 
 
0 
0.00 
 
1 
  
 
45-49 
0 
0.00 
 
0 
0.00 
 
1 
9.09 
 
0 
0.00 
 
1 
  
 
50-54 
0 
0.00 
 
0 
0.00 
 
3 
27.27 
 
0 
0.00 
 
3 
  
 
55-59 
0 
0.00 
 
2 
28.57 
 
3 
27.27 
 
2 
50.00 
 
7 
  
 
60-64 
2 
50.00 
 
0 
0.00 
 
2 
18.18 
 
0 
0.00 
 
4 
  
 
65-69 
1 
25.00 
 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
 
1 
  
 
70-74 0 1 0 2 3 
 
 
 
 
  
90 
0.00 
 
14.29 
 
0.00 
 
50.00 
 
  
 
75+ 
1 
25.00 
 
0 
0.00 
 
1 
9.09 
 
0 
0.00 
 
2 
  
 
Total 4 
 
7 
 
11 
 
4 
 
26 
  
 
Appendix 6: Numbers of cases of lip squamous cell carcinoma, per 
age group per year for females 
 
Frequency 
Col Pct 
 
Table of age by year 
year 
age 
2004 2005 2006 2007 2008 
T
ot
al 
35-39 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
 
1 
33.3
3 
 
0 
0.00 
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50-54 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
 
1 
50.0
0 
 
 
55-59 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
 
1 
33.3
3 
 
1 
50.0
0 
 
 
60-64 
1 
50.0
0 
 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
  
65-69 
1 
50.0
0 
 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
  
70-74 
0 
0.00 
 
0 
0.00 
 
0 
0.00 
 
1 
33.3
3 
 
0 
0.00 
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75+ 
0 
0.00 
 
1 
100.0
0 
 
1 
100.0
0 
 
0 
0.00 
 
0 
0.00 
  
Total
. 
2 
 
1 
 
1 
 
3 
 
2 
 
9 
 
 
  
Appendix 7: Cumulative rate (%) of oral cancer for Sudanese 
males and females:  
 Lip Oral SCC 
Combined Oral 
& Lip SCC 
Oral 
malignancies 
Males 0.23% 0.55% 0.55% 0.23% 
Females 0.00% 0.29% 0.12 0.12 
 
Appendix 8: Cumulative risk (%) of oral cancer for male and 
female residents in Khartoum and Gezira: 
 
 Oral SCC Combined Oral & Lip SCC 
Males 0.16% 0.2% 
Females 0.1% 0.1% 
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